This case study reviews Labcorp MCS support of a global pulmonary inflammation clinical trial that was active in Australia, highlighting the benefits on a global level and the specific challenges faced in the Pacific country.

This case study shares how the Mobile Clinical Services team at Labcorp Drug Development helped enhance a sponsor's patient recruitment approach by providing site support services at key investigator sites.

EBF 2021 -- Multi-domain biologics can potentially induce anti-drug antibodies (ADA) with specificity to different domains.

BSI Congress 2021 -- Following the failure to predict the cytokine release syndrome (CRS) induced by TGN1412 in 2006, the need for improved predictive preclinical in vitro safety assessments has become a priority and a regulatory expectation.

It is imperative for marketing authorization holders (MAH) to analyze their existing operating models for maintaining mature products and consider how they can benefit from an integrated safety, regulatory and benefit-risk model.

Labcorp was approached by a company based in Europe, which produced pigments and needed to register six of these pigments in time for the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) 2018 submission deadline.

Each year, one out of every six United States healthcare dollars is spent on cardiovascular (CV) disease. Not surprisingly, CV conditions and procedures are subject to reimbursement and setting of care and quality measure policies, all of which can greatly affect a hospital's reimbursement.

Technology is growing at a fast clip in patient service hubs, but it's not a silver-bullet solution to stakeholder needs. Automation is providing speed and cost reduction for benefit reimbursement. But patients require personal support to access, understand and adhere to therapies for a successful outcome.

Through a comprehensive suite of in-home, local and virtual tools selected based on the unique needs of each trial and seamlessly integrated with an unparalleled network of global laboratories, we can deliver high-quality data and increased patient enrollment, engagement and retention.